Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Sweeney

Showing results (31-40 of 263) with videos related to

Pageof 27
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|October 3, 2015
Update in Urothelial Carcinoma: Novel Agents and Targeted TherapyElizabeth A Guancial, Jonathan E Rosenberg, Christopher J Sweeney
The New England Journal of Medicine|October 10, 2019
Enzalutamide in Metastatic Prostate Cancer. ReplyIan D Davis, Martin R Stockler, Christopher J Sweeney
Integrated Environmental Assessment and Management|April 4, 2026
Dose response OECD 216 studies for agrochemicalsChristopher J Sweeney, Melanie Bottoms, Kerry Hutcheson, et al.
European Urology Focus|July 21, 2017
Delivering Optimal Care for Metastatic Prostate Cancer: A Strengthening Alliance Between Urologists and Medical OncologistsAlberto Briganti, Maria De Santis, Gianluca Giannarini, et al.
Environmental Toxicology and Chemistry|February 23, 2025
Functional versus compositional tests in the risk assessment of the impacts of pesticides on the soil microbiomeChristopher J Sweeney, Melanie Bottoms, Rishabh Kaushik, et al.
Nature Reviews. Clinical Oncology|November 27, 2025
Personalized intensification of treatment for hormone-sensitive prostate cancerMichael A Cilento, Lisa M Butler, Louise Emmett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2019
What Does Metastasis-Free Survival Actually Mean?Christopher J Sweeney, Richard De Abreu Lourenco, Anis A Hamid, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Approach to Oligometastatic Prostate CancerBrandon Bernard, Boris Gershman, R Jeffrey Karnes, et al.
Cancer|November 27, 2019
Impact of age at diagnosis of de novo metastatic prostate cancer on survivalBrandon Bernard, Colin Burnett, Christopher J Sweeney, et al.
Clinical Genitourinary Cancer|October 16, 2013
Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related eventNoah M Hahn, Constantin T Yiannoutsos, Kristina Kirkpatrick, et al.
Pageof 27

Showing results (31-40 of 263) with videos related to

Sort By:
Pageof 27
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|October 3, 2015
Update in Urothelial Carcinoma: Novel Agents and Targeted TherapyElizabeth A Guancial, Jonathan E Rosenberg, Christopher J Sweeney
The New England Journal of Medicine|October 10, 2019
Enzalutamide in Metastatic Prostate Cancer. ReplyIan D Davis, Martin R Stockler, Christopher J Sweeney
Integrated Environmental Assessment and Management|April 4, 2026
Dose response OECD 216 studies for agrochemicalsChristopher J Sweeney, Melanie Bottoms, Kerry Hutcheson, et al.
European Urology Focus|July 21, 2017
Delivering Optimal Care for Metastatic Prostate Cancer: A Strengthening Alliance Between Urologists and Medical OncologistsAlberto Briganti, Maria De Santis, Gianluca Giannarini, et al.
Environmental Toxicology and Chemistry|February 23, 2025
Functional versus compositional tests in the risk assessment of the impacts of pesticides on the soil microbiomeChristopher J Sweeney, Melanie Bottoms, Rishabh Kaushik, et al.
Nature Reviews. Clinical Oncology|November 27, 2025
Personalized intensification of treatment for hormone-sensitive prostate cancerMichael A Cilento, Lisa M Butler, Louise Emmett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2019
What Does Metastasis-Free Survival Actually Mean?Christopher J Sweeney, Richard De Abreu Lourenco, Anis A Hamid, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Approach to Oligometastatic Prostate CancerBrandon Bernard, Boris Gershman, R Jeffrey Karnes, et al.
Cancer|November 27, 2019
Impact of age at diagnosis of de novo metastatic prostate cancer on survivalBrandon Bernard, Colin Burnett, Christopher J Sweeney, et al.
Clinical Genitourinary Cancer|October 16, 2013
Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related eventNoah M Hahn, Constantin T Yiannoutsos, Kristina Kirkpatrick, et al.
Pageof 27